These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35044839)

  • 41. Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study.
    Zhang H; Xie H; Li L
    J Endocrinol Invest; 2024 Feb; 47(2):443-453. PubMed ID: 37543985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.
    Berrington de Gonzalez A; Curtis RE; Gilbert E; Berg CD; Smith SA; Stovall M; Ron E
    Br J Cancer; 2010 Jan; 102(1):220-6. PubMed ID: 19935795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
    Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
    Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salivary gland malignancy and radioiodine therapy for thyroid cancer.
    Klubo-Gwiezdzinska J; Van Nostrand D; Burman KD; Vasko V; Chia S; Deng T; Kulkarni K; Wartofsky L
    Thyroid; 2010 Jun; 20(6):647-51. PubMed ID: 20470209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of radioactive iodine treatment of thyroid carcinoma.
    Lee SL
    J Natl Compr Canc Netw; 2010 Nov; 8(11):1277-86; quiz 1287. PubMed ID: 21081784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of low-cost thyroid follow-up in children treated with radiotherapy for primary tumors at high risk of developing a second thyroid tumor.
    Piccardo A; Foppiani L; Puntoni M; Hanau G; Calafiore L; Garaventa A; Arlandini A; Villavecchia G; Bianchi P; Cabria M
    Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):459-67. PubMed ID: 23090072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131)I dose over 37 GBq.
    Khang AR; Cho SW; Choi HS; Ahn HY; Yoo WS; Kim KW; Kang KW; Yi KH; Park DJ; Lee DS; Chung JK; Cho BY; Park YJ
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):117-23. PubMed ID: 25115234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management.
    Kumagai A; Reiners C; Drozd V; Yamashita S
    Endocr J; 2007 Dec; 54(6):839-47. PubMed ID: 17938505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer.
    Zhao X; Yang G; Zhang W; Dong Q; Yang Q
    Endocrine; 2022 May; 76(2):385-394. PubMed ID: 35122212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine.
    Sönmez B; Bektaş Ö; Erkut N; Sönmez M
    Turk J Haematol; 2021 Dec; 38(4):306-313. PubMed ID: 33749216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second primary malignancies in thyroid cancer patients.
    Rubino C; de Vathaire F; Dottorini ME; Hall P; Schvartz C; Couette JE; Dondon MG; Abbas MT; Langlois C; Schlumberger M
    Br J Cancer; 2003 Nov; 89(9):1638-44. PubMed ID: 14583762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study.
    Wang Y; Cai Y
    Sci Rep; 2024 Oct; 14(1):24623. PubMed ID: 39427001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma.
    Lang BH; Wong KP
    Ann Surg Oncol; 2011 Dec; 18(13):3559-65. PubMed ID: 21573833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.